Waters logo

WatersNYSE: WAT

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 November 1995

Next earnings report:

02 August 2024

Last dividends:

26 November 1996

Next dividends:

N/A
$17.20 B
-33%vs. 3y high
96%vs. sector
-27%vs. 3y high
48%vs. sector
-85%vs. 3y high
95%vs. sector
-37%vs. 3y high
66%vs. sector

Price

after hours | Wed, 03 Jul 2024 18:32:15 GMT
$290.00+$6.00(+2.11%)

Dividend

No data over the past 3 years
$636.84 M$700.08 M
$636.84 M$102.20 M

Analysts recommendations

Institutional Ownership

WAT Latest News

Uncharted Waters, Untapped Potential: 3 Stocks Ready to Make Waves
investorplace.com19 June 2024 Sentiment: -

Sometimes, the best stocks to buy are those talked the least about. But if you follow the institutional moves and see which major investment groups are picking up a stock then the clues for a strong rally are present.

Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?
zacks.com06 June 2024 Sentiment: NEUTRAL

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Waters (WAT) Expands Mass Spectrometer Portfolio With Xevo MRT
zacks.com04 June 2024 Sentiment: POSITIVE

Waters (WAT) boosts MS offerings with the launch of Xevo MRT, strengthening its Waters operating segment's portfolio.

Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
prnewswire.com03 June 2024 Sentiment: POSITIVE

News Summary: Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromising analytical performance.i Delivers up to 6x resolution at maximum speed and up to 2x mass accuracy of competitive systems,ii enabling scientists to process more samples in less time for large-cohort biomedical research and epidemiology-type studies. Complete workflows available for metabolomic, lipidomic, and metabolite identification enables customer flexibility and convenience using Waters™ software, columns, and instruments for high throughput separations, and universal data-sharing with third-party software applications.

Mayfair Gold: Muddy Waters' Lawsuit is Wholly Without Merit
globenewswire.com28 May 2024 Sentiment: POSITIVE

MATHESON, Ontario, May 28, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today commented on an ex parte order obtained by Muddy Waters Capital LLC (“Muddy Waters”) in the Supreme Court of British Columbia on May 27 restricting the distribution of funds held in trust of approximately $4.0 million representing the aggregate termination payments payable to the Company's management and employees under their employment agreements in respect of a change of control. The trust arrangement for the change of control payments was described in the Company's press release dated May 9, 2024. The order was obtained by Muddy Waters without notice to the Company, its employees or directors and without the opportunity for the Company, its employees or directors to be heard before the Court.

Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
PRNewsWire13 May 2024 Sentiment: POSITIVE

On May 13, 2024, Waters Corporation (NYSE:WAT) revealed that Udit Batra Ph.D.

Waters (WAT) International Revenue in Focus: Trends and Expectations
Zacks Investment Research13 May 2024 Sentiment: POSITIVE

Analyze the international revenue trends of Waters (WAT) and how they may impact Wall Street's predictions and the future direction of the stock.

Waters (WAT) to Report Q1 Earnings: What's in the Offing?
Zacks Investment Research06 May 2024 Sentiment: POSITIVE

Waters' (WAT) performance in the first quarter of 2024 is expected to show growth in the large molecule and PFAS testing sectors, despite a decrease in demand from China.

Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics
Zacks Investment Research02 May 2024 Sentiment: NEUTRAL

Look beyond analysts' predictions for Waters (WAT) and consider projections for key metrics to get a clearer picture of the company's performance in the quarter ending March 2024.

Waters (WAT) Boosts Waters Operating Segment With HPLC System
Zacks Investment Research11 April 2024 Sentiment: POSITIVE

Waters introduces Alliance iS Bio HPLC system to enhance productivity in biopharma quality control labs, contributing to growth in its Waters Operating division.

  • 1(current)
  • 2
  • 3

What type of business is Waters?

Waters Corporation is an American company specializing in the development and provision of measuring instruments and tools. It was founded in 1958, with its headquarters located in Milford, Massachusetts. The company's activities include the development, production, sales, and servicing of high-performance liquid chromatography (HPLC) systems, ultra high-performance liquid chromatography (UHPLC) systems, and mass spectrometry technological systems and products, including chromatographic columns, other consumables, and comprehensive post-warranty service plans. Additionally, the company develops and manufactures instruments for thermal analysis, rheometry, and calorimetry, as well as modern software solutions that interact with the equipment and systems.

What sector is Waters in?

Waters is in the Healthcare sector

What industry is Waters in?

Waters is in the Diagnostics & Research industry

What country is Waters from?

Waters is headquartered in United States

When did Waters go public?

Waters initial public offering (IPO) was on 17 November 1995

What is Waters website?

https://www.waters.com

Is Waters in the S&P 500?

Yes, Waters is included in the S&P 500 index

Is Waters in the NASDAQ 100?

No, Waters is not included in the NASDAQ 100 index

Is Waters in the Dow Jones?

No, Waters is not included in the Dow Jones index

When does Waters report earnings?

The next expected earnings date for Waters is 02 August 2024